Acorda Gets Interim OK For $60M DIP With $40M Rollup

By Ben Zigterman · April 4, 2024, 7:10 PM EDT

Acorda Therapeutics Inc., a developer of drug treatments for neurological disorders, received on Thursday interim approval to access $10 million of a $60 million debtor-in-possession loan package from a group of...

To view the full article, register now.